Early intervention in pediatric-onset MS can lead to improved long-term outcomes

New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term disability in multiple sclerosis (MS) patients.

Liquidia sues FDA over exclusivity decision to delay Yutrepia’s full approval

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 23, 2024

Drinking water quality violations disproportionately affect the most vulnerable communities, study reveals

A new study published in IOP Publishing’s journal Environmental Research Letters examines the links between drinking water quality violations and social vulnerability in the United

September 5, 2023

FDA accepts Alpha Cognition’s NDA for Alzheimer’s treatment

Share this article ALPHA-1062 is intended to treat mild-to-moderate Alzheimer’s disease. Credit: PopTika / Shutterstock.com. The US Food and Drug Administration (FDA) has accepted Alpha

December 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.